Title : ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin.

Pub. Date : 2021 Oct 8

PMID : 34375763






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin treatment decreased ATXN7L3B-induced tumor-initiating ability in a HCC mouse model, implying that metformin may inhibit cancer stemness by downregulating ATXN7L3B. Metformin ataxin 7-like 3B Mus musculus
2 Metformin treatment decreased ATXN7L3B-induced tumor-initiating ability in a HCC mouse model, implying that metformin may inhibit cancer stemness by downregulating ATXN7L3B. Metformin ataxin 7-like 3B Mus musculus
3 Metformin treatment decreased ATXN7L3B-induced tumor-initiating ability in a HCC mouse model, implying that metformin may inhibit cancer stemness by downregulating ATXN7L3B. Metformin ataxin 7-like 3B Mus musculus
4 Metformin treatment decreased ATXN7L3B-induced tumor-initiating ability in a HCC mouse model, implying that metformin may inhibit cancer stemness by downregulating ATXN7L3B. Metformin ataxin 7-like 3B Mus musculus